Sedation in Intensive Care Unit Patients Completed Phase 4 Trials for Midazolam (DB00683)

Also known as: Sedation in Intensive Care / Intensive Care Unit sedation

IndicationStatusPhase
DBCOND0067366 (Sedation in Intensive Care Unit Patients)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02022592Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive CareTreatment